Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial

被引:14
作者
Skovlund, Pernille Christiansen [1 ,2 ,3 ]
Vind Thaysen, Henriette [3 ,4 ]
Schmidt, Henrik [2 ]
Alsner, Jan [1 ]
Hjollund, Niels Henrik [5 ,6 ,7 ]
Lomborg, Kirsten [3 ,6 ,8 ]
Nielsen, Berit Kjaerside [3 ,9 ]
机构
[1] Aarhus Univ Hosp, Dept Oncol, Expt Clin Oncol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[3] Aarhus Univ & Cent Denmark Reg, Res Ctr Patient Involvement, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[4] Aarhus Univ Hosp, Dept Surg, Aarhus N, Denmark
[5] Hosp Unit West Jutland, AmbuFlex Ctr Patient Reported Outcomes, Herning, Denmark
[6] Aarhus Univ, Dept Clin Med, Fac Hlth, Aarhus N, Denmark
[7] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus N, Denmark
[8] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[9] DEFACTUM, Social & Hlth Serv & Labour Market, Aarhus N, Denmark
关键词
Patient-reported outcomes; communication; patient activation measure; HRQoL; metastatic melanoma; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY; ACTIVATION; CARE; COMMUNICATION; VALIDATION; INTERVENTIONS; INSTRUMENT; SYMPTOMS; VALIDITY;
D O I
10.1080/0284186X.2021.1962972
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background With increased survival among patients with metastatic melanoma and limited time with health care providers, patients are expected to assume a more active role in managing their treatment and care. Activated patients have the knowledge, skills, and confidence to make effective solutions to self-manage health. The use of patient-reported outcomes (PRO) could have the potential to enhance patient activation. However, PRO-based interventions that facilitate an activation in patients with metastatic melanoma are lacking and warranted. Material and methods In this prospective non-randomized controlled, clinical trial, patients with metastatic melanoma were assigned to either the intervention (systematic feedback and discussion of PRO during consultation) given at one hospital or the control group (treatment as usual) if they received treatment from two other hospitals in Denmark. The primary outcome was the patient activation measure (PAM), which reflects self-management. Secondary outcomes were health-related quality of life (HRQoL), self-efficacy, and Patient-Physician interaction. Outcomes were measured at baseline, and after 3, 6, and 12 months. The analysis of the effect from baseline to 12 months employed mixed-effects modeling. Results Between 2017 and 2019, patients were allocated to either the intervention group (n = 137) or the control group (n = 142). We found no significant difference in the course of patient activation between the two groups over time. The course of HRQoL was statistically significantly improved by the intervention compared to the control group. Especially, females in the intervention group performed better than males. The other secondary outcomes were not improved by the intervention. Conclusion The intervention did not improve knowledge, skills, and confidence for self-management for patients with metastatic melanoma. Neither did it improve coping self-efficacy nor perceived efficacy in Patient-Physician interaction. However, the results suggest that the intervention can have a significant impact on HRQoL and in particular social and emotional well-being among the females.
引用
收藏
页码:1668 / 1677
页数:10
相关论文
共 60 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Transforming the Patient Role to Achieve Better Outcomes Through a Patient Empowerment Program: A Randomized Wait-List Control Trial Protocol [J].
Altshuler, Lisa ;
Plaksin, Joseph ;
Zabar, Sondra ;
Wallach, Andrew ;
Sawicki, Chester ;
Kundrod, Sarita ;
Kalet, Adina .
JMIR RESEARCH PROTOCOLS, 2016, 5 (02)
[3]   Evaluating Minimal Important Differences for the FACT-Melanoma Quality of Life Questionnaire [J].
Askew, Robert L. ;
Xing, Yan ;
Palmer, J. Lynn ;
Cella, David ;
Moye, Lemuel A. ;
Cormier, Janice N. .
VALUE IN HEALTH, 2009, 12 (08) :1144-1150
[4]   Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial [J].
Basch, Ethan ;
Stover, Angela M. ;
Schrag, Deborah ;
Chung, Arlene ;
Jansen, Jennifer ;
Henson, Sydney ;
Carr, Philip ;
Ginos, Brenda ;
Deal, Allison ;
Spears, Patricia A. ;
Jonsson, Mattias ;
Bennett, Antonia V. ;
Mody, Gita ;
Thanarajasingam, Gita ;
Rogak, Lauren J. ;
Reeve, Bryce B. ;
Snyder, Claire ;
Kottschade, Lisa A. ;
Charlot, Marjory ;
Weiss, Anna ;
Bruner, Deborah ;
Dueck, Amylou C. .
JCO CLINICAL CANCER INFORMATICS, 2020, 4 :947-957
[5]  
Basch Ethan, 2018, Am Soc Clin Oncol Educ Book, V38, P122, DOI 10.1200/EDBK_200383
[6]   Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial [J].
Basch, Ethan ;
Wood, William A. ;
Schrag, Deborah ;
Sima, Camelia S. ;
Shaw, Mary ;
Rogak, Lauren J. ;
Kris, Mark G. ;
Shouery, Marwan ;
Bennett, Antonia ;
Atkinson, Thomas ;
Pietanza, M. Catherine .
CLINICAL TRIALS, 2016, 13 (03) :331-337
[7]   Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial [J].
Basch, Ethan ;
Deal, Allison M. ;
Kris, Mark G. ;
Scher, Howard I. ;
Hudis, Clifford A. ;
Sabbatini, Paul ;
Rogak, Lauren ;
Bennett, Antonia V. ;
Dueck, Amylou C. ;
Atkinson, Thomas M. ;
Chou, Joanne F. ;
Dulko, Dorothy ;
Sit, Laura ;
Barz, Allison ;
Novotny, Paul ;
Fruscione, Michael ;
Sloan, Jeff A. ;
Schrag, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) :557-+
[8]  
Bjelland I., 2002, Journal of Psychosomatic Research, V52, P69, DOI [DOI 10.1016/S0022-3999(01)00296-3, 10.1016/S0022-3999]
[9]   Patient and Disease Characteristics Associated with Activation for Self-Management in Patients with Diabetes, Chronic Obstructive Pulmonary Disease, Chronic Heart Failure and Chronic Renal Disease: A Cross-Sectional Survey Study [J].
Bos-Touwen, Irene ;
Schuurmans, Marieke ;
Monninkhof, Evelyn M. ;
Korpershoek, Yvonne ;
Spruit-Bentvelzen, Lotte ;
Ertugrul-van der Graaf, Inge ;
de Wit, Niek ;
Trappenburg, Jaap .
PLOS ONE, 2015, 10 (05)
[10]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579